RxSight (RXST) Inventory Average (2021 - 2026)

RxSight (RXST) has reported Inventory Average for 6 consecutive years, with $38.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 50.42% year-over-year to $38.3 million; the trailing twelve-month figure through Jun 2026 stood at $38.3 million (up 50.42% YoY), and the FY2025 full-year result was $28.1 million, up 38.52% from the prior year.
• Inventory Average rose to $38.3 million in Q2 2026 per RXST's latest filing, from $35.1 million in the prior quarter.
• Across five years, Inventory Average topped out at $38.3 million in Q2 2026 and bottomed at $8.4 million in Q1 2022.
• Historically, Inventory Average has averaged $21.4 million across 5 years, with a median of $19.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Inventory Average surged 101.93% in 2023, then grew 6.75% in 2024.
• Over 5 years, Inventory Average stood at $15.6 million in 2022, then rose by 19.19% to $18.6 million in 2023, then advanced by 20.7% to $22.5 million in 2024, then jumped by 42.32% to $32.0 million in 2025, then gained by 19.76% to $38.3 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $38.3 million, $35.1 million, and $32.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.